טוען...
Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer
The aim of this study was to investigate the value of serum macrophage inhibitory factor‐1 (MIC‐1) level in patients with non–small cell lung cancer (NSCLC). Serum samples from 296 patients with NSCLC and 240 healthy controls were collected. The levels of serum MIC‐1 were determined by ELISA. The se...
שמור ב:
| הוצא לאור ב: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957168/ https://ncbi.nlm.nih.gov/pubmed/33605059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16360 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|